Quantitative structure-activity relationship studies on sulfonamide-based MMP inhibitors.

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• Matrix metalloproteinases (MMPs) are crucial enzymes involved in numerous physiological processes.
• Overactivation of MMPs is implicated in severe diseases including arthritis, cancer metastasis, and heart failure.
• Targeting MMPs with inhibitors is a significant area of pharmaceutical research.

Purpose of the Study:

• To comprehensively review and critically assess quantitative structure-activity relationship (QSAR) studies on sulfonamide-based MMP inhibitors.
• To provide insights into the structure-activity relationships of sulfonamides for improved drug design.
• To identify potential leads for developing novel pharmaceutical agents targeting MMPs.

Main Methods:

• Literature search and compilation of reported QSAR studies on sulfonamide MMP inhibitors.
• Critical analysis of QSAR methodologies and findings.
• Assessment of the predictive power and limitations of existing QSAR models.

Main Results:

• Numerous sulfonamide derivatives have demonstrated potential as MMP inhibitors.
• QSAR studies have provided valuable guidelines for designing more potent compounds.
• Few sulfonamide-based MMP inhibitors have advanced to clinical trials, highlighting the need for improved drug design strategies.

Conclusions:

• Sulfonamide derivatives represent a promising class of compounds for MMP inhibition.
• Further QSAR-driven research is essential to optimize the design of effective and safe MMP inhibitors.
• This review serves as a resource for medicinal chemists aiming to develop novel therapeutics for MMP-related diseases.